Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026)
Beyond Air (XAIR) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 9.52% |
| 10 | Beyond Air | 3.73 Mn | -7.18 Mn | 225,000.00 | -23.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23.14% |
| Mar 31, 2026 | -26.82% |
| Dec 31, 2025 | -62.29% |
| Sep 30, 2025 | -36.55% |
| Jun 30, 2025 | -8.45% |
| Mar 31, 2025 | -139.07% |
| Dec 31, 2024 | 8.62% |
| Sep 30, 2024 | 25.67% |
| Jun 30, 2024 | 362.61% |
| Mar 31, 2024 | 358.76% |
| Dec 31, 2023 | 112.67% |
| Sep 30, 2023 | 51.11% |
| Jun 30, 2023 | 48.35% |
| Mar 31, 2023 | 408.45% |
| Dec 31, 2022 | 292.16% |
| Sep 30, 2022 | 303.82% |
| Jun 30, 2022 | 336.04% |
| Mar 31, 2022 | 332.89% |
| Dec 31, 2021 | 198.38% |
| Mar 31, 2021 | 171.44% |